Biopsy Procedure

AUG 18, 2026 · PHASE 1 TRIAL

Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer

ClinicalTrials.gov

Phase 1 trial of a three-drug combination in metastatic breast cancer with dose-limiting toxicity as the primary endpoint; no results posted in this registry record.

AUG 12, 2026 · PHASE 2 TRIAL

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

ClinicalTrials.gov

This is a Phase 2 trial registry record with only 5 enrolled participants and no results posted; it represents early-phase work that requires confirmation.

AUG 10, 2026 · PHASE 2 TRIAL

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

ClinicalTrials.gov

Phase 2 trial in recruitment with no results posted; study design and patient population are defined but outcomes remain unreported.

AUG 10, 2026 · PHASE 1 TRIAL

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

ClinicalTrials.gov

This is a Phase 1 trial registration with no results posted; it describes planned enrollment and safety endpoints only, without outcome data.

AUG 7, 2026 · PHASE 2 TRIAL

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

ClinicalTrials.gov

This is a Phase 2 screening trial registry record with no reported results; it describes planned enrollment and procedural outcomes only, not clinical efficacy or safety data.